Browsing Tag: Cardiovascular Risk Reduction

Key Highlights:  Implications:  Extensior catapults Abbott into the GLP-1 frenzy, grabbing prime shelf space before generics from Eris/Natco crash prices by half—think explosive Tier-2 growt...